1. Home
  2. IDT vs CTMX Comparison

IDT vs CTMX Comparison

Compare IDT & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDT Corporation Class B

IDT

IDT Corporation Class B

HOLD

Current Price

$51.84

Market Cap

1.2B

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.19

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDT
CTMX
Founded
1990
2008
Country
United States
United States
Employees
1925
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
977.1M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
IDT
CTMX
Price
$51.84
$4.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$80.00
$12.10
AVG Volume (30 Days)
88.6K
3.7M
Earning Date
06-04-2026
05-08-2026
Dividend Yield
0.55%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,201,000.00
Revenue This Year
$4.34
N/A
Revenue Next Year
N/A
$7.61
P/E Ratio
$15.10
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$45.72
$0.91
52 Week High
$71.12
$8.21

Technical Indicators

Market Signals
Indicator
IDT
CTMX
Relative Strength Index (RSI) 57.41 41.91
Support Level $46.85 $3.94
Resistance Level $52.57 $4.33
Average True Range (ATR) 1.33 0.26
MACD -0.04 -0.02
Stochastic Oscillator 63.57 16.06

Price Performance

Historical Comparison
IDT
CTMX

About IDT IDT Corporation Class B

IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: